| Source: |
| Type: |
| A pro-apoptotic protein that plays a crucial role in regulating cell death, particularly in the context of cancer. BIM is a member of the BCL-2 family of proteins, which are key regulators of apoptosis (programmed cell death). BIM cancer is characterized by the overexpression of the BIM protein, which is a pro-apoptotic protein that promotes cell death. BIM protein has been shown to have both tumor-suppressive and tumor-promoting roles, depending on the context. High BIM expression: Melanoma, lung, breast, colorectal. Low BIM expression: Leukemia, Lymphoma, Prostate The expression of BIM can serve as a prognostic marker in several cancers. Higher levels of BIM are often associated with increased apoptosis and better treatment responses, while lower levels may indicate resistance to therapy and poorer outcomes. |
| Ovarian Cancer |
| 266- | ALA, | Lipoic acid decreases Mcl-1, Bcl-xL and up regulates Bim on ovarian carcinoma cells leading to cell death |
| - | in-vitro, | Ovarian, | IGROV1 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:20 Cells:% prod#:% Target#:483 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid